We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

Back to rankings

85 hedge funds and large institutions have $443M invested in Foundation Medicine, Inc. in 2013 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

825% more capital invested

Capital invested by funds: $47.9M → $443M (+$396M)

756% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 9

400% more funds holding

Funds holding: 17 → 85 (+68)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
85
Holders Change
+68
Holders Change %
+400%
% of All Funds
2.47%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
77
Increased
4
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
+$54.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$46.7M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20.2M
4
PG
PEAK6 Group
Illinois
+$11.1M
5
DM
Deerfield Management
New York
+$9.67M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$14M
2
PC
Pier Capital
Connecticut
-$6.35M
3
DCM
Driehaus Capital Management
Illinois
-$3.18M
4
Ameriprise
Ameriprise
Minnesota
-$2.53M
5
PWAM
Park West Asset Management
California
-$1.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
TAM
76
Tocqueville Asset Management
New York
$36K +$41.9K +1,500 New
TRCT
77
Tower Research Capital (TRC)
New York
$34K +$39.9K +1,427 New
BJ
78
BlackRock Japan
Japan
$34K +$39.9K +1,429 New
HDIM
79
Hanson & Doremus Investment Management
Vermont
$8K +$9.37K +335 New
Creative Planning
80
Creative Planning
Kansas
$6K +$7.55K +270 New
PNC Financial Services Group
81
PNC Financial Services Group
Pennsylvania
$5K +$5.59K +200 New
BlackRock
82
BlackRock
New York
$4K +$4.45K +159 New
BNP Paribas Financial Markets
83
BNP Paribas Financial Markets
France
$2K +$2.35K +84 New
US Bancorp
84
US Bancorp
Minnesota
$1K +$867 +31 New
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 +$4.78K +171 New
PC
86
Pier Capital
Connecticut
– -$6.35M -160,149 Closed
DCM
87
Driehaus Capital Management
Illinois
– -$3.18M -80,183 Closed
PWAM
88
Park West Asset Management
California
– -$1.98M -50,000 Closed
Alyeska Investment Group
89
Alyeska Investment Group
Illinois
– -$1.89M -47,580 Closed
EA
90
Emerald Advisers
Pennsylvania
– -$739K -18,650 Closed
EMFAT
91
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$450K -11,350 Closed
GA
92
Geneva Advisors
Illinois
– -$224K -5,640 Closed
MCM
93
Mazama Capital Management
Oregon
– -$40K -1,000 Closed
TRSOTSOK
94
Teachers Retirement System of the State of Kentucky
Kentucky
– -$28K -700 Closed
1 2 3
4

FMI Hedge Fund Activity: Q4 2013 in Review

85 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2013, worth a combined $443M — up 825% from $47.9M a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new FMI positions and 9 closed out — a net gain of 68 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $54.4M. The largest seller was Citadel Advisors, cutting an estimated $14M.

  • 85 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2013, up from 17 in Q3 2013.
  • Funds reported $443M of Foundation Medicine, Inc. stock for Q4 2013, up 825% quarter-over-quarter.
  • 77 funds opened new Foundation Medicine, Inc. positions in Q4 2013 and 9 closed out, a net change of +68 holders.
  • The largest Foundation Medicine, Inc. buyer in Q4 2013 was Gilder Gagnon Howe & Co, an estimated $54.4M added.
  • The largest Foundation Medicine, Inc. seller in Q4 2013 was Citadel Advisors, an estimated $14M sold.

Based on aggregated 13F filings for Q4 2013.